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Abstract:We present a case of nodal recurrence of carcinoid tumor in
a 48-year-old male patient, 30 years after resection of primary tumor.
Octreoscan was used for diagnosis and localization of the mass. Sur-
gical resection was successful and histopathologic examination re-
vealed lymph node infiltrated with atypical carcinoid.
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Bronchial carcinoids (typical and atypical) are a part of thespectrum of neuroendocrine tumors of the lung; despite
being low-grade malignant tumors, they may spread to me-
diastinal lymph nodes or distantly even many years after
surgical resection.
CASE SUMMARY
In January 2007, a 48-year-old man came to our atten-
tion because of a mediastinal mass discovered incidentally on
chest x-ray performed during cardiac check up for infrequent
dropped beats (Figure 1A). The patient is nonsmoker and, he
denied any chest related complaint or dysphagia. In 1977, he
had undergone a right lower lobectomy for a carcinoid tumor.
Diagnostic work up included chest computed tomography
scan that revealed a large mass measuring 11  9  6 cm
with small area of calcification, occupying the subcarinal area
with flaring of both bronchi and compression of the esopha-
gus (Figure 1B). Esophagoscopy was performed to exclude
primary esophageal tumor and the findings were only external
compression with normal intact mucosa. The serum was
positive for Neurone Specific Enolase 18.4 g/liter (normal
values 0.0–17.0 g/liter) and the level of 5-hydroxyindola-
cetic acid in 24-hour urine was elevated to 290 mol (normal
values 10–31 mol); a picture suggestive of carcinoid tumor,
however, there was no clinical evidence of carcinoid syn-
drome. OctreoScan (using octreotide radiolabeled with In-
dium 111) revealed high uptake by the mass and no abnormal
uptake elsewhere (Figure 2). Through right rethoracotomy,
the lung was retracted anteriorly and mediastinal pleura over
the mass was opened; at first the mass was dissected from the
esophagus and then from both bronchi and posterior pericar-
dium, feeding vessels were clipped and divided. During the
procedure, attention was paid to avoid further compression of
the heart. Mediastinal lymph node dissection was performed
followed by hemostasis and closure of thoracotomy (Figure
3). Histopathological examination of the mass revealed soli-
tary lymph node infiltrated with atypical carcinoid tumor.
Apart from right paraesophageal lymph node that showed
micrometastasis, all other lymph nodes were free. Revision of
the histopathology of the primary tumor resected 30 years
previously was consistent with atypical carcinoid. In the last
follow-up 10 months after surgery, the patient is doing well
with unremarkable chest x ray.
COMMENT
Recurrence of carcinoid tumors after surgical resection
varies between 2–9% and 5–30% for typical and atypical
varieties, respectively. In a study of 139 patients with re-
sected pulmonary carcinoids, recurrence developed in 8 pa-
tients at postoperative intervals of 43 25 months.1 Few case
reports described recurrence more than 20 years after initial
resection. Atypical variety and presence of positive lymph
nodes at the time of primary resection are predictors for
regional or systemic recurrence.2
Somatostatin receptor scintigraphy, with Radiolabeled
somatostatin analogue 111In-octreotide is used to localize
carcinoid tumor and has demonstrated reliable results both in
diagnosis of primary carcinoids and detection of early recur-
rences and metastases even in asymptomatic patients. It has a
sensitivity of more than 90% and can be used as the initial
diagnostic imaging modality.3 In our patient, due to the
increased Neurone Specific Enolase and 5-hydroxyindolace-
tic acid serum levels, recurrent carcinoid was the leading
diagnosis and the octreotide scan helped to support this
diagnosis and excluded spread elsewhere that would have
precluded surgery. Bronchoscopic needle aspiration would
have given a tissue diagnosis, but would not have defined
extent of disease and was not needed before surgery.
At the present time, surgical resection of the primary
tumor and local lymph nodes is the only curative treatment
available, other treatment modalities with chemotherapeutic
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agents, biotherapy with somatostatin analogues or interfer-
ons, and radiolabeled peptides have only modest effect in
controlling tumor progression. Our previous4 results and this
case emphasize the importance of mediastinal lymphadenec-
tomy in cases of carcinoid tumors at the time of the original
resection and life-long follow up of resected carcinoid pa-
tients, especially if local lymph node involvement was
present.
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FIGURE 1. A, x-ray chest showing large central
mediastinal mass. B, Chest CT scan showing the
size of the mass and its anatomic relations.
FIGURE 2. 111In-octreotide scentigraphy (OctreoScan)
whole body images obtained 4 hours after injection showing
abnormal high uptake by the mass (black arrow) and normal
uptake by the liver, kidneys, and bladder.
FIGURE 3. The resected mass opened longitudinally show-
ing anatomic features of lymph node with tumor infiltration.
Journal of Thoracic Oncology • Volume 3, Number 6, June 2008 Nodal Recurrence of Pulmonary Carcinoid
Copyright © 2008 by the International Association for the Study of Lung Cancer 681
